Global Lung Cancer Diagnostic Tests Market Survey and Trend Research 2018

September 2018 | 76 pages | ID: GCA1D7072CEEN
99Strategy

Abstracts

Summary

This report describes the development of the industry by upstream & downstream, industry overall and development, key companies, as well as type segment & market application and so on, and makes a scientific prediction for the development industry prospects on the basis of analysis, finally, analyzes opportunities for investment in the industry at the end of the report.

Industry Chain

• Raw Materials
• Cost
• Technology
• Consumer Preference

Industry Overall:

• History
• Development & Trend
• Market Competition
• Trade Overview
• Policy

Region (North America, Europe, Asia-Pacific, South America, Middle East, Africa):

• Regional Market
• Production Development
• Sales
• Regional Trade
• Regional Forecast

Company (Advpharma Inc, AIT Austrian Institute of Technology GmbH, Courtagen Life Sciences Inc, DiagnoCure Inc. (Inactive), BioMarker Strategies LLC, BioMarker Strategies LLC, Emory University, Epigenomics AG, GlycoZym, HalioDx SAS, Louisville Bioscience, Inc., Mayo Clinic US etc.):

• Company Profile
• Product & Service
• Business Operation Data
• Market Share

Investment Analysis:

• Market Features
• Investment Opportunity
• Investment Calculation

Contents

PART 1 INDUSTRY OVERVIEW

1.1 Lung Cancer Diagnostic Tests Industry
  1.1.1 Definition
  1.1.2 Industry Trend
1.2 Industry Chain
  1.2.1 Upstream
  1.2.2 Technology
  1.2.3 Cost Structure
  1.2.4 Consumer Preference
  1.2.2 Downstream

PART 2 INDUSTRY OVERALL

2.1 Industry History
2.2 Development Prospect
2.3 Competition Structure
2.4 Relevant Policy
2.5 Trade Overview

PART 3 LUNG CANCER DIAGNOSTIC TESTS MARKET BY PRODUCT

3.1 Products List of Major Companies
3.2 Market Size
3.3 Market Forecast

4 KEY COMPANIES LIST

4.1 Advpharma Inc (Company Overview, Sales Data etc.)
  4.1.1 Company Overview
  4.1.2 Products and Services
  4.1.3 Business Analysis
4.2 AIT Austrian Institute of Technology GmbH (Company Overview, Sales Data etc.)
  4.2.1 Company Overview
  4.2.2 Products and Services
  4.2.3 Business Analysis
4.3 Courtagen Life Sciences Inc (Company Overview, Sales Data etc.)
  4.3.1 Company Overview
  4.3.2 Products and Services
  4.3.3 Business Analysis
4.4 DiagnoCure Inc. (Inactive) (Company Overview, Sales Data etc.)
  4.4.1 Company Overview
  4.4.2 Products and Services
  4.4.3 Business Analysis
4.5 BioMarker Strategies LLC (Company Overview, Sales Data etc.)
  4.5.1 Company Overview
  4.5.2 Products and Services
  4.5.3 Business Analysis
4.6 BioMarker Strategies LLC (Company Overview, Sales Data etc.)
  4.6.1 Company Overview
  4.6.2 Products and Services
  4.6.3 Business Analysis
4.7 Emory University (Company Overview, Sales Data etc.)
  4.7.1 Company Overview
  4.7.2 Products and Services
  4.7.3 Business Analysis
4.8 Epigenomics AG (Company Overview, Sales Data etc.)
  4.8.1 Company Overview
  4.8.2 Products and Services
  4.8.3 Business Analysis
4.9 GlycoZym (Company Overview, Sales Data etc.)
  4.9.1 Company Overview
  4.9.2 Products and Services
  4.9.3 Business Analysis
4.10 HalioDx SAS (Company Overview, Sales Data etc.)
  4.10.1 Company Overview
  4.10.2 Products and Services
  4.10.3 Business Analysis
4.11 Louisville Bioscience, Inc. (Company Overview, Sales Data etc.)
4.12 Mayo Clinic US (Company Overview, Sales Data etc.)

PART 5 MARKET COMPETITION

5.1 Companies Competition
5.2 Industry Competition Structure Analysis
  5.2.1 Rivalry
  5.2.2 Threat of New Entrants
  5.2.3 Substitutes
  5.2.4 Bargaining Power of Suppliers
  5.2.5 Bargaining Power of Buyers

PART 6 MARKET DEMAND BY SEGMENT

6.1 Demand Situation
  6.1.1 Industry Application Status
  6.1.2 Industry SWOT Analysis
    6.1.2.1 Strengths
    6.1.2.2 Weaknesses
    6.1.2.3 Opportunities
    6.1.2.4 Threats
6.2 Major Customer Survey
6.3 Demand Forecast

PART 7 REGION OPERATION

7.1 Regional Market
7.2 Production and Sales by Region
  7.2.1 Production
  7.2.2 Sales
  7.2.3 Trade
7.3 Regional Forecast

PART 8 MARKET INVESTMENT

8.1 Market Features
  8.1.1 Product Features
  8.1.2 Price Features
  8.1.3 Channel Features
  8.1.4 Purchasing Features
8.2 Investment Opportunity
  8.2.1 Regional Investment Opportunity
  8.2.2 Industry Investment Opportunity
8.3 Investment Calculation
  8.3.1 Cost Calculation
  8.3.2 Revenue Calculation
  8.3.3 Economic Performance Evaluation

PART 9 CONCLUSION

List Of Tables

LIST OF TABLES

Table Global Lung Cancer Diagnostic Tests Market 2012-2017, by Type, in USD Million
Table Global Lung Cancer Diagnostic Tests Market Forecast 2018-2023, by Type, in USD Million
Table Advpharma Inc Overview List
Table Lung Cancer Diagnostic Tests Business Operation of Advpharma Inc (Sales Revenue, Cost, Gross Margin)
Table AIT Austrian Institute of Technology GmbH Overview List
Table Lung Cancer Diagnostic Tests Business Operation of AIT Austrian Institute of Technology GmbH (Sales Revenue, Cost, Gross Margin)
Table Courtagen Life Sciences Inc Overview List
Table Lung Cancer Diagnostic Tests Business Operation of Courtagen Life Sciences Inc (Sales Revenue, Cost, Gross Margin)
Table DiagnoCure Inc. (Inactive) Overview List
Table Lung Cancer Diagnostic Tests Business Operation of DiagnoCure Inc. (Inactive) (Sales Revenue, Cost, Gross Margin)
Table BioMarker Strategies LLC Overview List
Table Lung Cancer Diagnostic Tests Business Operation of BioMarker Strategies LLC (Sales Revenue, Cost, Gross Margin)
Table BioMarker Strategies LLC Overview List
Table Lung Cancer Diagnostic Tests Business Operation of BioMarker Strategies LLC (Sales Revenue, Cost, Gross Margin)
Table Emory University Overview List
Table Lung Cancer Diagnostic Tests Business Operation of Emory University (Sales Revenue, Cost, Gross Margin)
Table Epigenomics AG Overview List
Table Lung Cancer Diagnostic Tests Business Operation of Epigenomics AG (Sales Revenue, Cost, Gross Margin)
Table GlycoZym Overview List
Table Lung Cancer Diagnostic Tests Business Operation of GlycoZym (Sales Revenue, Cost, Gross Margin)
Table HalioDx SAS Overview List
Table Lung Cancer Diagnostic Tests Business Operation of HalioDx SAS (Sales Revenue, Cost, Gross Margin)
Table Louisville Bioscience, Inc. Overview List
Table Lung Cancer Diagnostic Tests Business Operation of Louisville Bioscience, Inc. (Sales Revenue, Cost, Gross Margin)
Table Mayo Clinic US Overview List
Table Lung Cancer Diagnostic Tests Business Operation of Mayo Clinic US (Sales Revenue, Cost, Gross Margin)
Table Global Lung Cancer Diagnostic Tests Sales Revenue 2012-2017, by Companies, in USD Million
Table Global Lung Cancer Diagnostic Tests Sales Revenue Share, by Companies, in USD Million
Table Lung Cancer Diagnostic Tests Demand 2012-2017, by Application, in USD Million
Table Lung Cancer Diagnostic Tests Demand Forecast 2018-2023, by Application, in USD Million
Table Global Lung Cancer Diagnostic Tests Market 2012-2017, by Region, in USD Million
Table Lung Cancer Diagnostic Tests Market Forecast 2018-2023, by Region, in USD Million

List Of Figures

LIST OF FIGURES

Figure Lung Cancer Diagnostic Tests Industry Chain Structure
Figure Global Lung Cancer Diagnostic Tests Market Growth 2012-2017, by Type, in USD Million
Figure Global Lung Cancer Diagnostic Tests Sales Revenue Share, by Companies in 2017, in USD Million
Figure Production Development by Region
Figure Sales List by Region